- Login
- Register & Subscribe
- Language: EN FR DE
Boehringer Ingelheim GmbH, reported a 2.8% decline in sales in the first half of 2010, mainly due to generic competition in the US. But it said new product sales would help it achieve a high, single-digit increase in 2011.
Germany
Friday February 10 2012
Friday February 10 2012
Tuesday February 7 2012
Friday February 3 2012
Monday January 23 2012